Education β’ Testing Guides β’ Advocacy β’ Community for Breast Implant Illness (BII/ASIA)
This is a resource hub for women, families, and healthcare providers seeking evidence-based information about breast implant illness (BII) and autoimmune/autoinflammatory syndrome induced by adjuvants (ASIA).
Created by and for breast implant survivors, with science-backed content.
Learn what BII/ASIA is, how silicone implants trigger immune reactions, and why symptoms vary.
Download a doctor's visit checklist with labs, imaging, and specialist referrals based on latest research.
Find support groups, read survivor stories, and join the advocacy movement for informed consent and safety.
Silicone breast implants trigger a chronic inflammatory response through several mechanisms:
Result: Chronic fatigue, autoimmunity, and systemic symptoms in susceptible women.
ASIA = Autoimmune/Autoinflammatory Syndrome Induced by Adjuvants (also called "silicone incompatibility syndrome" or BII in the US)
Defined in 2011 by Shoenfeld, ASIA describes a syndrome where an implanted medical device or adjuvant (silicone, aluminum, polypropylene mesh, etc.) triggers autoimmune disease in susceptible individuals.
~95% of self-reported BII patients meet ASIA criteria.
| Finding | Source / Data |
|---|---|
| 45% increased risk of autoimmune disease in women with implants | Watad et al. 2018 meta-analysis (24,651 women with implants vs. 98,604 matched controls) |
| ~25% of unselected implant patients have ASIA symptoms | Cohen Tervaert pilot study (4x higher than healthy controls) |
| 60β80% show symptom improvement after explant | Multiple cohort studies including Cohen Tervaert 2022 |
| 90% of BII patients meet CFS/ME criteria | Cohen Tervaert 2022 Expert Review |
| 90% of BII patients meet fibromyalgia criteria | Cohen Tervaert 2022 Expert Review |
| BIA-ALCL (anaplastic large cell lymphoma) risk: 1 in 2,832 women | van der Meulen et al. 2018 (macrotextured implants especially) |
Silicone implants do NOT cause classic autoimmune disease in all women. Rather, in genetically/immunologically susceptible women, silicone acts as a "trigger."
Bottom line: Not all women with implants develop BII, but those with genetic predisposition, immune dysregulation, or allergic history are at higher risk. Silicone is not "toxic to everyone"βit is an adjuvant problem in susceptible individuals.
Characteristic features:
In studies, the median time between implant surgery and onset of BII symptoms is:
This highlights why many women don't initially connect implants to later-onset systemic illness.
Use this as a tool to take to your appointments:
The checklist includes:
Directory of plastic surgeons, rheumatologists, immunologists, and other specialists trained in BII diagnosis and explant surgery.
Connect with other survivors for emotional support, explant surgery prep, post-recovery healing, and advocacy.
Healing Breast Implant Illness Society (150k+ members) Breast Implant Safety Alliance (BISA)Peer-reviewed papers, expert reviews, and evidence-based information on BII/ASIA.
Cohen Tervaert et al. (2022) Expert Review of Clinical Immunology FDA Breast Implant Safety InformationFocus: Largest peer support community (150,000+ members)
Offerings: Facebook groups, emotional support, education, fundraising
Visit WebsiteFocus: Evidence-based information, informed consent, policy advocacy
Offerings: Patient checklists, FDA collaboration, media outreach, surveys
Visit WebsiteFocus: Specifically BIA-ALCL (lymphoma) education and support
Offerings: Disease education, legal advocacy, cancer patient support
Visit WebsiteFocus: Doctor training, research dissemination, patient-doctor matching
Offerings: Certified surgeon directory, research updates, education
Visit WebsiteFocus: Evidence compilation, informed consent, FDA advocacy
Key Work: Patient/doctor checklists, Black Box Warning advocacy
Focus: Broader women's health; involved in implant safety policy
Currently, there is no dedicated nonprofit focused on BII legal advocacy (class actions, manufacturer liability, regulatory enforcement). This is a major gap.
Existing organizations with some legal involvement:
(Anonymized survivor account)
2012: Cosmetic augmentation (saline implants). 2015: Chronic fatigue started; doctors blamed stress. 2018: Developed Raynaud's and joint pain; rheumatology workup inconclusive. 2022: Explant after BII diagnosis. 2023: 80% symptom improvement.
Key takeaway: Long lag between implant and systemic symptoms; many doctors don't connect the dots.
(Anonymized survivor account)
2010: Breast reconstruction after mastectomy (gel implants). 2018: Severe fatigue, brain fog, autoimmune markers appearing. 2023: Explant + capsulectomy + physical therapy. 6 months post-explant: energy returning, labs improving, returning to work part-time.
Key takeaway: Reconstruction patients need BII monitoring; explant + rehabilitation can restore quality of life.
(Anonymized survivor account)
2014: Cosmetic augmentation with macrotextured implants. 2021: Sudden swelling of one breast; imaging showed seroma. Biopsy: CD30+ BIA-ALCL. 2021β2023: Chemotherapy + explant. Currently in remission.
Key takeaway: BIA-ALCL is rare but serious; early imaging and biopsy diagnosis crucial.
We're collecting survivor stories to build a repository. Your anonymized account helps:
As stories are collected, we'll publish anonymized insights:
BII affects 1+ million women, yet:
Change requires patient voices, policy pressure, and community action.
Gap: ASIA affects women with hip implants, hernia mesh, vaccines (in susceptible people), and other adjuvantsβbut advocacy is fragmented.
What's Needed: A unified ASIA advocacy nonprofit that bridges all adjuvant exposures.
You can help: Create content connecting BII to broader ASIA awareness; advocate for international ASIA recognition.
Gap: No formal CME/CEU curriculum for diagnosing BII/ASIA. Front-line doctors lack training.
What's Needed: Online courses, grand rounds, medical school modules on BII testing protocols.
You can help: Create educational videos; partner with medical schools; fund curriculum development.
Gap: No centralized registry tracking BII cases, diagnostics, treatments, outcomes. Epidemiology unclear.
What's Needed: Open-source, IRB-approved registry collecting anonymized patient data.
You can help: Participate in registries; advocate for data standardization; help publicize findings.
Gap: BII has no ICD-10 diagnosis code; explant denied as "cosmetic" instead of medical.
What's Needed: Push for official ICD-10 code; insurance coverage campaigns; legal class actions.
You can help: Document insurance denials; support class action lawsuits; contact legislators.
Gap: No evidence-based post-explant recovery protocols. Claims about "detoxification" lack rigor.
What's Needed: Research on post-explant healing; rehabilitation guidelines; immune restoration protocols.
You can help: Fund research; create post-explant recovery guides; share your recovery timeline.
Gap: BII patients with CFS/ME-like fatigue lack disability support and workplace accommodation advocacy.
What's Needed: ADA accommodation guides; disability benefits advocacy; partnership with ME/CFS groups.
You can help: Share workplace challenges; advocate for disability recognition; connect BII + ME/CFS communities.
Gap: BII is under-recognized outside North America. Different regulatory standards worldwide.
What's Needed: International BII advocacy network; local chapters in Europe, Asia, Australia; global surveillance.
You can help: Create multilingual content; build global social media networks; advocate with international regulators.
Gap: Limited resources for psychological impact of explant, body dysmorphia, grief.
What's Needed: Therapists trained in BII trauma; support groups; body image counseling.
You can help: Connect survivors with mental health resources; normalize mental health discussions; fund therapy access.
As a content creator, you can amplify BII awareness through videos, social media, articles, and more. Here are resources: